Literature DB >> 10674949

Comorbidity of the anxiety disorders in a community-based older population in The Netherlands.

A J van Balkom1, A T Beekman, E de Beurs, D J Deeg, R van Dyck, W van Tilburg.   

Abstract

OBJECTIVE: The aim of the study was to investigate patterns of comorbidity among the anxiety disorders in a community-based older population, and the relationship of these disorders with major depression, use of alcohol and benzodiazepines, cognitive impairment and chronic somatic illnesses.
METHOD: The data were derived from the Longitudinal Aging Study Amsterdam (LASA) study. A two-stage screening design was adopted to identify respondents with anxiety disorders.
RESULTS: In total, 10% of the elderly with an anxiety diagnosis suffered from two or more anxiety disorders. Major depression (13% vs. 3%), benzodiazepine use (24% vs. 11%) and chronic somatic diseases (12% vs. 7%) were significantly more prevalent in respondents with an anxiety disorder than in respondents without anxiety disorders. Heavy or excessive alcohol intake (5% vs. 4%) and cognitive impairment (11% vs. 13%) were not significantly associated with any anxiety disorder.
CONCLUSION: When anxiety disorders are diagnosed, in older people there is a relatively high probability of comorbid conditions being present.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674949     DOI: 10.1034/j.1600-0447.2000.101001037.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  13 in total

Review 1.  Comorbidity of depression and anxiety in the elderly.

Authors:  Eric J Lenze
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

2.  Correlates of anxiety symptoms in physically disabled older women.

Authors:  Gretchen A Brenes; Jack M Guralnik; Jeff Williamson; Linda P Fried; Brenda W J H Penninx
Journal:  Am J Geriatr Psychiatry       Date:  2005-01       Impact factor: 4.105

3.  Childhood Traumatic Experiences, Anxiety, and Depression Levels in Fibromyalgia and Rheumatoid Arthritis.

Authors:  Korhan Bayram; Almıla Erol
Journal:  Noro Psikiyatr Ars       Date:  2014-12-01       Impact factor: 1.339

4.  Effects of medical comorbidity on anxiety treatment outcomes in primary care.

Authors:  Laura Campbell-Sills; Murray B Stein; Cathy D Sherbourne; Michelle G Craske; Greer Sullivan; Daniela Golinelli; Ariel J Lang; Denise A Chavira; Alexander Bystritsky; Raphael D Rose; Stacy Shaw Welch; Gene A Kallenberg; Peter Roy-Byrne
Journal:  Psychosom Med       Date:  2013-07-25       Impact factor: 4.312

Review 5.  Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options.

Authors:  Alastair J Flint
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  Late-life anxiety disorders: a review.

Authors:  Josien Schuurmans; Anton van Balkom
Journal:  Curr Psychiatry Rep       Date:  2011-08       Impact factor: 5.285

Review 7.  The association between somatic symptoms, anxiety disorders and substance use. A literature review.

Authors:  Imran Hassan; Rizwan Ali
Journal:  Psychiatr Q       Date:  2011-12

8.  Evaluation of the factor structure and psychometric properties of the Brief Symptom Inventory-18 with homebound older adults.

Authors:  Andrew J Petkus; Amber M Gum; Brent Small; Vanessa L Malcarne; Murray B Stein; Julie Loebach Wetherell
Journal:  Int J Geriatr Psychiatry       Date:  2010-06       Impact factor: 3.485

Review 9.  Diagnosis and management of panic disorder in older patients.

Authors:  Alastair J Flint; Nadine Gagnon
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.

Authors:  Brenda W J H Penninx; Aartjan T F Beekman; Johannes H Smit; Frans G Zitman; Willem A Nolen; Philip Spinhoven; Pim Cuijpers; Peter J De Jong; Harm W J Van Marwijk; Willem J J Assendelft; Klaas Van Der Meer; Peter Verhaak; Michel Wensing; Ron De Graaf; Witte J Hoogendijk; Johan Ormel; Richard Van Dyck
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.